低氧作为一种目标,用于结合在肝细胞癌中经动脉化学栓塞的治疗
Zizhuo Wang1, Qing Li2, Bin Liang1
1Hubei Key Laboratory of Molecular Imaging, Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan 430022, China.
肝细胞癌 (HCC) 中的缺氧驱动瘤生长和治疗阻力. 在跨动脉化血栓化 (TACE) 期间向缺氧可能会提高HCC治疗疗效.
科学领域:
- 在瘤学瘤学.
- 瘤微环境研究 研究
背景情况:
- 缺氧是肝细胞癌 (HCC) 的关键特征,影响瘤进展和治疗耐药性.
- 超动脉化学栓塞 (TACE) 是无法切除的HCC的标准治疗方法,但可以诱导缺氧.
- 缺氧诱导因子1 (HIF-1) 调解TACE诱导的缺氧对血管生成,新陈代谢,EMT和免疫的影响.
研究的目的:
- 审查低氧对HCC生物学多方面的影响.
- 检查TACE诱导的缺氧对治疗结果的不良影响.
- 突出结合低氧向疗法与TACE用于HCC治疗的潜力.
主要方法:
- 对HCC中缺氧研究的文献综述.
- 分析HIF-1在TACE诱导的瘤变化中的作用.
- 综合证据的低氧向策略在HCC.
主要成果:
- 缺氧促进HCC的进展,血管生成,改变的新陈代谢,EMT和免疫规避.
- 通过激活HIF-1通路,TACE诱导的缺氧可以抵消其自身的治疗效益.
- 向缺氧是一种有希望的策略,可以提高TACE的疗效.
结论:
- 了解缺氧在HCC中的作用对于优化TACE至关重要.
- 将TACE与低氧向治疗相结合,为HCC提供了一个新的治疗途径.
- 需要进一步的研究来将这些发现转化为临床实践.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
